David R Strong1,2, Karen Messer3,4, Sheri J Hartman3,4, Jesse Nodora3,4, Lisa Vera3, Martha M White3, Eric Leas3,4, Nikolas Pharris-Ciurej5, Nicolette Borek5, John P Pierce3,4. 1. Cancer Prevention Program, Moores Cancer Center, University of California, San Diego, 3855 Health Sciences Drive MC0901, La Jolla, San Diego, CA, 92093-0901, USA. dstrong@ucsd.edu. 2. Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, San Diego, CA, USA. dstrong@ucsd.edu. 3. Cancer Prevention Program, Moores Cancer Center, University of California, San Diego, 3855 Health Sciences Drive MC0901, La Jolla, San Diego, CA, 92093-0901, USA. 4. Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, San Diego, CA, USA. 5. Center for Tobacco Products, US Food and Drug Administration, Silver Spring, MD, USA.
Abstract
BACKGROUND: This study extends research on receptivity to tobacco marketing over a key developmental period for cigarette smoking experimentation. PURPOSE: The purpose of this study was to understand the effect of receptivity to tobacco marketing and exposure to friends who smoke on smoking experimentation. METHODS: Participants were 10 to 13 years old who had never tried cigarettes (n = 878), interviewed six times at 8-month intervals. RESULTS: At baseline, 25% percent of the 10 and 11 years old in the sample of never smokers were receptive to tobacco marketing, while less than 5% had friends who smoked. Having a friend who smoked at study baseline and acquiring such friends for the first time during the study were the strongest predictors of smoking experimentation. Initial receptivity to tobacco marketing increased the risk of smoking experimentation independently of having friends who smoke at baseline or acquiring friends who smoke throughout the study period. CONCLUSIONS: The high level of receptivity observed even among 10 and 11 years old and its robust relationship with cigarette smoking experimentation independent of the significant risk associated with having friends who smoke suggests that successful prevention of receptivity may require intervention at an early age.
BACKGROUND: This study extends research on receptivity to tobacco marketing over a key developmental period for cigarette smoking experimentation. PURPOSE: The purpose of this study was to understand the effect of receptivity to tobacco marketing and exposure to friends who smoke on smoking experimentation. METHODS:Participants were 10 to 13 years old who had never tried cigarettes (n = 878), interviewed six times at 8-month intervals. RESULTS: At baseline, 25% percent of the 10 and 11 years old in the sample of never smokers were receptive to tobacco marketing, while less than 5% had friends who smoked. Having a friend who smoked at study baseline and acquiring such friends for the first time during the study were the strongest predictors of smoking experimentation. Initial receptivity to tobacco marketing increased the risk of smoking experimentation independently of having friends who smoke at baseline or acquiring friends who smoke throughout the study period. CONCLUSIONS: The high level of receptivity observed even among 10 and 11 years old and its robust relationship with cigarette smoking experimentation independent of the significant risk associated with having friends who smoke suggests that successful prevention of receptivity may require intervention at an early age.
Authors: Robert J Wellman; Erika N Dugas; Hartley Dutczak; Erin K O'Loughlin; Geetanjali D Datta; Béatrice Lauzon; Jennifer O'Loughlin Journal: Am J Prev Med Date: 2016-05-11 Impact factor: 5.043
Authors: Jonathan B Bricker; K Bharat Rajan; Maureen Zalewski; Madelaine Ramey; Arthur V Peterson; M Robyn Andersen Journal: Health Psychol Date: 2009-07 Impact factor: 4.267
Authors: Janet Audrain-McGovern; Caryn Lerman; E Paul Wileyto; Daniel Rodriguez; Peter G Shields Journal: Am J Psychiatry Date: 2004-07 Impact factor: 18.112
Authors: Karin A Kasza; Kathryn C Edwards; Zhiqun Tang; Cassandra A Stanton; Eva Sharma; Michael J Halenar; Kristie A Taylor; Elisabeth Donaldson; Lynn C Hull; Hannah Day; Maansi Bansal-Travers; Jean Limpert; Izabella Zandberg; Lisa D Gardner; Hoda T Hammad; Nicolette Borek; Heather L Kimmel; Wilson M Compton; Andrew Hyland Journal: Tob Control Date: 2020-05 Impact factor: 7.552
Authors: Cassandra A Stanton; Eva Sharma; Elizabeth L Seaman; Karin A Kasza; Kathryn C Edwards; Michael J Halenar; Kristie A Taylor; Hannah Day; Gabriella Anic; Lynn C Hull; Maansi Bansal-Travers; Jean Limpert; Lisa D Gardner; Hoda T Hammad; Nicolette Borek; Heather L Kimmel; Wilson M Compton; Andrew Hyland Journal: Tob Control Date: 2020-05 Impact factor: 7.552
Authors: John P Pierce; James D Sargent; Martha M White; Nicolette Borek; David B Portnoy; Victoria R Green; Annette R Kaufman; Cassandra A Stanton; Maansi Bansal-Travers; David R Strong; Jennifer L Pearson; Blair N Coleman; Eric Leas; Madison L Noble; Dennis R Trinidad; Meghan B Moran; Charles Carusi; Andrew Hyland; Karen Messer Journal: Pediatrics Date: 2017-06 Impact factor: 7.124
Authors: John P Pierce; James D Sargent; David B Portnoy; Martha White; Madison Noble; Sheila Kealey; Nicolette Borek; Charles Carusi; Kelvin Choi; Victoria R Green; Annette R Kaufman; Eric Leas; M Jane Lewis; Katherine A Margolis; Karen Messer; Yuyan Shi; Marushka L Silveira; Kimberly Snyder; Cassandra A Stanton; Susanne E Tanski; Maansi Bansal-Travers; Dennis Trinidad; Andrew Hyland Journal: JAMA Pediatr Date: 2018-05-01 Impact factor: 16.193